Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Role of CSPG receptor LAR phosphatase in restricting axon regeneration after CNS injury

Role of CSPG receptor LAR phosphatase in restricting axon regeneration after CNS injury

Neurobiol Dis, 2015 · DOI: 10.1016/j.nbd.2014.08.030 · Published: January 1, 2015

Spinal Cord InjuryRegenerative MedicineNeurology

Simple Explanation

Extracellular matrix molecule chondroitin sulfate proteoglycans (CSPGs) are highly upregulated in scar tissues and form a potent chemical barrier for CNS axon regeneration. The receptor protein tyrosine phosphatase σ (PTPσ) and its subfamily member leukocyte common antigen related phosphatase (LAR) act as transmembrane receptors to mediate CSPG inhibition. LAR deletion increased regrowth of serotonergic axons into scar tissues and caudal spinal cord after dorsal overhemitransection. LAR deletion also stimulated regrowth of CST fibers into the caudal spinal cord.

Study Duration
5 Weeks
Participants
LAR+/+, +/− and −/− mice
Evidence Level
Not specified

Key Findings

  • 1
    LAR deletion increased regrowth of serotonergic axons into scar tissues and caudal spinal cord after dorsal overhemitransection.
  • 2
    LAR deletion also stimulated regrowth of CST fibers into the caudal spinal cord.
  • 3
    LAR deletion improved functional recovery by increasing BMS locomotor scores and stride length and reducing grid walk errors.

Research Summary

In this study, we demonstrate that transgenic deletion of LAR increased growth of descending serotonergic axons and CST fibers in reactive scar tissues and caudal spinal cord after SCI. Furthermore, LAR deletion improved functional recovery by increasing BMS locomotor scores, reducing grid walk errors and enhancing stride length of the hindlimbs weeks after SCI. Thus, our findings support the crucial role of LAR in restricting axon regrowth after CNS injury.

Practical Implications

Therapeutic Target

LAR phosphatase presents a potential therapeutic target for promoting axon regeneration after CNS injury.

Combination Therapies

Simultaneous blockade of CSPG receptors, including PTPσ, LAR, and NgRs, may achieve greater axonal regeneration and functional recovery.

Improved Functional Outcomes

LAR deficiency enhances functional recovery after SCI, offering prospects for improved patient outcomes.

Study Limitations

  • 1
    [object Object]
  • 2
    [object Object]
  • 3
    [object Object]

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury